Most of us tend to think of heart health as something to worry about later. After the kids are older. After work settles down. After we turn 50 and the doctor starts looking at us a little differently. Heart disease is something that happens to our parents, or maybe our parents’ friends. Not us. Not yet. By the way, you may be the age that your parents were when you thought they were old!
This is an understandable assumption. It’s also one that the medical community has spent the last decade trying to correct.
Because here’s what the research keeps showing us: the groundwork for cardiovascular disease is laid long before anyone clutches their chest. The arterial plaque that causes a heart attack at 60 often started accumulating quietly in someone’s 30s and 40s. The elevated LDL cholesterol that gets flagged as “something to watch” in middle age has sometimes been elevated for twenty years.
The window to meaningfully change the trajectory of your cardiovascular health is not in your 60s. It’s NOW, wherever you are.
The Shift That’s Happening in Mainstream Medicine
In March 2026, the American College of Cardiology and the American Heart Association, along with nine other major medical organizations, released a comprehensive update to their guidelines on the management of dyslipidemia. It was the first major revision since 2018, and it changed several things that matter.
Perhaps the most significant shift: the new guidelines now recommend that cardiovascular risk screening begin at age 30.¹
Not 40. Not 50. Thirty.
The guidelines also introduced a new risk calculation tool called PREVENT (Predicting Risk of Cardiovascular Disease EVENTs) which replaces an older model that had been in use since 2013. The older tool had a known problem: it tended to overestimate risk in some groups and underestimate it in others, and it was calibrated primarily on 10-year projections, which makes a 35-year-old look falsely low-risk.¹ ² The new PREVENT calculator looks at both 10-year and 30-year risk, built from data on over 6.5 million adults, and it removes race as a variable while adding kidney function as a predictor, making it more accurate and more equitable.³
The shift to 30-year risk assessment is a fundamental change in how we think about cardiovascular prevention. Your 10-year risk at 35 is almost always going to look fine on paper. But your 30-year risk? That’s where the story gets more interesting, and more actionable.
Why Earlier Matters: The Cholesterol Conversation
Think of LDL cholesterol (the “bad” kind) less like a number and more like a running tab. Every year your arteries are exposed to elevated levels, the tab goes up. The plaque doesn’t disappear between readings. It accumulates.
Dr. Steven Nissen, chief academic officer at the Cleveland Clinic Heart, Vascular and Thoracic Institute, put it plainly: the time-averaged value of your LDL cholesterol over your lifetime is one of the strongest predictors of whether you’ll have a cardiac event. It’s not about a single data point, it’s about the total exposure.⁴
The new guidelines reflect this understanding directly. For the first time, the ACC/AHA now recommends that adults as young as 30 with an LDL of 160 mg/dL or higher, or a strong family history of premature heart disease, begin a conversation about lipid-lowering strategies, including medication if lifestyle changes aren’t sufficient.¹ The emphasis is on reducing lifetime exposure, not just managing a number that crossed a threshold on a Tuesday afternoon.
For people with familial hypercholesterolemia (an inherited condition where LDL is structurally elevated) the guidelines now recommend screening beginning in childhood, around age 9 or earlier.⁵ This is a genetic situation, but it’s a useful illustration of the broader principle: the longer elevated cholesterol circulates, the more cumulative damage it does.
What Your Numbers Actually Mean — And Which Ones to Ask For
A standard lipid panel gives you total cholesterol, LDL, HDL, and triglycerides. This is the baseline, and it’s still worth having. But the 2026 guidelines also highlight two biomarkers that can meaningfully sharpen the picture:
Lipoprotein(a), often written as Lp(a), is a lesser-known lipid particle that is largely genetically determined and not well addressed by standard lipid-lowering treatments. The new guidelines recommend that everyone have their Lp(a) measured at least once in their lifetime, because it can flag elevated cardiovascular risk even when other numbers look normal.¹
Apolipoprotein B (ApoB) is another marker the guidelines now recommend as a complement to LDL. ApoB reflects the total number of atherogenic (plaque-forming) particles in the blood, which can tell a more complete story than LDL alone, particularly for people with metabolic syndrome, insulin resistance, or elevated triglycerides.¹
Beyond lipids, a complete early cardiovascular workup reasonably includes blood pressure (with a target below 120/80), fasting glucose and HbA1c to assess blood sugar regulation, and body composition or waist circumference as a proxy for metabolic health. The 2025 ACC/AHA high blood pressure guidelines similarly call for individualized, proactive monitoring, with emphasis on identifying risk earlier and tailoring interventions before disease progresses.⁶
These are not exotic tests. Most of them are available through routine lab work. The key is simply asking for them, and starting earlier than you might have thought necessary.
The Number to Know Is Not Just the One You Already Have
There’s a pattern I see in practice that’s worth naming. Someone comes in who has had annual physicals for years. Their cholesterol has been “borderline” for a decade. No one has ever really dug into what that means for their long-term risk. It’s been noted, maybe followed, but not truly addressed.
The new guidelines are partly a response to that exact dynamic. The focus is shifting from “is this number in the danger zone today?” to “what is this trajectory telling us about the next 30 years, and what can we do now?”
At 30 or 35 or 40, there is typically time, real meaningful time, to change the trajectory. Dietary changes can reduce LDL and triglycerides. Regular physical activity improves HDL, lowers blood pressure, and reduces insulin resistance. Weight management reduces inflammatory burden on the vascular system. Stress and sleep, which influence cortisol and metabolic function, are increasingly recognized as genuine cardiovascular risk factors, not soft lifestyle topics.
The lifestyle tools available to us in our 30s and 40s are genuinely powerful. They work differently at that stage of life than they do at 60, when decades of accumulated risk may have narrowed the options. This is the argument for starting sooner; not to create anxiety, but to preserve optionality. You want to be making these decisions from a place of abundance, not crisis management.
A Simple Starting Point
If you’re in your 30s and haven’t had a cardiovascular baseline done, or if it’s been several years since anyone looked at the full picture, here’s a reasonable starting point:
A fasting lipid panel that includes total cholesterol, LDL, HDL, and triglycerides, along with Lp(a) at least once. A fasting glucose and HbA1c. A blood pressure reading. A conversation about family history, specifically whether any first-degree relatives had a cardiac event before age 55 (for men) or 65 (for women).
That’s not a complicated list. It’s a morning at the lab and a conversation with a clinician who takes the long view.
My practice approaches cardiovascular health through a nutritional and functional lens, understanding the upstream factors driving your numbers, and building a plan based on what’s actually going on in your body, not just what a chart says. If you’ve been meaning to take a closer look, this is a good moment. Click on START HERE on my homepage to book a discovery call.
The research has caught up with what many of us have suspected for years: starting later is not the same as starting when it matters.
References
- Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. J Am Coll Cardiol. Published online March 13, 2026. doi: 10.1016/j.jacc.2025.11.016.
- Khan SS, Coresh J, Pencina MJ, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023;148(24):1982–2004. doi: 10.1161/CIR.0000000000001165. PMID: 37947094.
- AI-HEART Lab. 2026 ACC/AHA Lipid Guideline Calculator: PREVENT-ASCVD Model Overview. Available at: https://www.ai-heart.org/tools/lipid-2026. Accessed June 2026.
- Nissen S. Quoted in: “Cholesterol screening and treatment for younger adults, new guidelines suggest.” NBC News. March 17, 2026. Available at: https://www.nbcnews.com/health/heart-health/cholesterol-lipids-guidelines-screenings-american-heart-association-rcna263017.
- Hopkins Medicine News. The New Cholesterol Guideline: What to Know. Johns Hopkins Medicine. March 27, 2026. Available at: https://www.hopkinsmedicine.org/news/newsroom/news-releases/2026/03/the-new-cholesterol-guideline-what-to-know.
- Whelton PK, Carey RM, Aronow WS, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation. 2025. doi: 10.1161/CIR.0000000000001356.
